← Open Payments lookup

RYAN MORGAN: Open Payments

NPI 1033454616 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$110,578 in 169 payments from 15 companies in 2025. Trend: 2023 $44,629 · 2024 $43,672 · 2025 $110,578

Speaker / faculty: $64,225Consulting: $41,790Travel & lodging: $1,992Honoraria: $1,287Food & beverage: $1,267Education: $19
CompanyPaymentsAmount
Lilly USA, LLC119$66,769
Kedplasma LLC12$39,000
Novo Nordisk Inc9$2,959
Rhythm Pharmaceuticals, Inc.4$1,352
ABBVIE INC.7$150
Madrigal Pharmaceuticals5$116
Novartis Pharmaceuticals Corporation3$47
Corcept Therapeutics2$45
Amgen Inc.2$40
Alexion Pharmaceuticals, Inc.1$22

Products named: ZEPBOUND, IMCIVREE, REZDIFFRA, Ozempic, MOUNJARO, Wegovy, CREON, LEQVIO.

Industry payments across OK — which companies pay providers there.